Article info
PDFRespiratory medicine
Research
Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
- Correspondence to Dr Katsutoshi Ando; kando{at}juntendo.ac.jp
Citation
Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
Publication history
- Received May 3, 2014
- Revised July 30, 2014
- Accepted July 31, 2014
- First published August 14, 2014.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/